Variable | Birmingham (n=10 152) | Variable | CDC USA (n=277 013) |
---|---|---|---|
Age (median, IQR) | 35.0 (23.0–55.0) | ||
Age categories | Age categories | ||
<16 | 1264 (12.5%) | <5 | 10 217 (3.7%) |
16–25 | 1960 (19.3%) | 5–14 | 7123 (2.6%) |
26–35 | 1990 (19.6%) | 15–24 | 25 534 (9.2%) |
36–45 | 1358 (13.4%) | 25–44 | 97 349 (35.1%) |
46–55 | 1101 (10.6%) | 45–64 | 76 262 (27.5%) |
over 55 | 2479 (24.4%) | >64 | 60 528 (21.9%) |
Gender | Gender | ||
Female | 4902 (48.3%) | Male | 173 621 (62.7%) |
Male | 5250 (51.7%) | Female | 103 392 (37.3%) |
Ethnicity | Ethnicity | ||
White | 1991 (19.6%) | American Indian or Alaska Native | 3532 (1.3%) |
Indian Subcontinent | 6233 (61.4%) | Asian or Pacific Islander | 56 962 (20.6%) |
Afro-Caribbean | 1484 (14.6%) | Black or African American | 86 697 (31.3%) |
Oriental/other Asia | 220 (2.2%) | Hispanic or Latino | 66 934 (24.2%) |
Other | 224 (2.2%) | White, non-Hispanic | 62 888 (22.7%) |
Place of birth | Place of birth | ||
UK | 3612 (35.6%) | USA | 153 598 (55.4%) |
Foreign-born | 6540 (64.4%) | Foreign-born | 123 415 (44.6%) |
Time since entry to the UK (years)* | Time since entry to the US (years)† | ||
<1 | 331 (5.7%) | <1 | 23 897 (23.7%) |
1–5 | 1943 (33.3%) | 1–4 | 24 990 (24.8%) |
6–10 | 818 (14.0%) | 5–14 | 27 467 (27.3%) |
>10 | 2740 (47.0%) | 15+ | 24 280 (24.1%) |
Employment status‡ | Employment status§ | ||
Unemployed | 447 (11.4%) | Unemployed | 144 308 (59.0%) |
Retired | 334 (8.5%) | Employed | 100 345 (41.0%) |
Employed/housewife | 1670 (42.4%) | ||
Student/child | 1486 (37.7%) | ||
HIV status¶ | HIV status** | ||
Negative | 171 (88.6%) | Negative | 101 606 (77.9%) |
Positive | 22 (11.4%) | Positive | 28 836 (22.1%) |
Previous TB†† | Previous TB‡‡ | ||
No | 4777 (95.3%) | No | 260 527 (94.8%) |
Yes | 236 (4.7%) | Yes | 14 350 (5.2%) |
Type of disease | Type of disease | ||
Pulmonary only | 5590 (55.1%) | Pulmonary only | 203 449 (73.4%) |
Pulmonary and extrapulmonary | 763 (7.5%) | Pulmonary and extrapulmonary | 21 524 (7.8%) |
Extrapulmonary only | 3799 (37.4%) | Extrapulmonary only | 52 040 (18.8%) |
Site of extrapulmonary disease | |||
Intrathoracic lymph node | 525 (11.5%) | ||
Extrathoracic lymph node | 1907 (41.8%) | ||
Bone and joint | 461 (10.1%) | ||
Central nervous system | 169 (3.7%) | ||
Pleura | 505 (11.7%) | ||
Peritoneum | 108 (2.4%) | ||
Genitourinary | 180 (4.0%) | ||
Intestinal | 212 (4.7%) | ||
Miliary | 198 (4.3%) | ||
Pericardial | 51 (1.1%) | ||
Soft tissue | 101 (2.2%) | ||
Other | 538 (11.8%) | ||
Culture positive§§ | Culture positive¶¶ | ||
No | 5398 (53.2%) | No | 56 072 (20.2%) |
Yes | 4754 (46.8%) | Yes | 220 941 (79.8%) |
Drug sensitivity*** | Drug sensitivity††† | ||
Fully sensitive | 1634 (91.8%) | Not multidrug resistant | 206 274 (98.5%) |
Monodrug resistant | 116 (6.5%) | Multidrug resistant | 3154 (1.5%) |
Multidrug resistant | 30 (1.7%) | ||
Resident in correctional facility‡‡‡ | |||
No | 264 422 (96.3%) | ||
Yes | 10 237 (3.7%) |
*Only applies to foreign-born individuals; data available for 5832 individuals.
†Only applies to foreign-born individuals; unknown for 22 781.
‡Data available for 3937 individuals.
§Unknown for 32 360.
¶Data available for 193 individuals.
**Unknown for 146 571.
††Data available for 5013 individuals.
‡‡Unknown for 2136.
§§Culture positive for 3134/5590 (56.1%) pulmonary only cases, 1246/2553 (32.8%) extrapulmonary only cases and 374/763 (49.0%) pulmonary and extrapulmonary cases.
¶¶Culture positive for 165 319/203 449 (81.3%) pulmonary only cases, 36 994/52 040 (71.1%) extrapulmonary only cases and 18 628/21 524 (86.5%) pulmonary and extrapulmonary cases.
***Data available for 1780 individuals.
†††Only relevant to culture positive cases; unknown for 11 513.
‡‡‡Unknown for 2354.
CDC, Centers for Disease Control.